SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001213900-16-019019
Filing Date
2016-11-29
Accepted
2016-11-29 16:32:51
Documents
3

Document Format Files

Seq Description Document Type Size
1 PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM F-3 ff32016a1_biondvaxpharma.htm F-3/A 80656
2 OPINION OF PEARL COHEN ZEDEK LATZER BARATZ, LLP ff32016a1ex5ii_biondvax.htm EX-5.2 16298
3 GRAPHIC image_001.jpg GRAPHIC 2804
  Complete submission text file 0001213900-16-019019.txt   101917
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: F-3/A | Act: 33 | File No.: 333-214439 | Film No.: 162023083
SIC: 2836 Biological Products, (No Diagnostic Substances)